Witness Credibility Analysis
USPTO’s Proposed “One and Done” IPR Rule: Rethinking Finality, Fairness, and Efficiency
The USPTO’s recently published notice of proposed rulemaking (RIN 0651-AD89, Docket No. PTO-P-2025-0025) for inter partes review (IPR) ...
NIS 2: One Year Later
Member States were required to implement the NIS 2 Directive ("NIS 2") into national law by 17 October 2024. One year on, many EU Membe...
Cyberfraud: A New Era of False Claims Act Liability Risk
Top Five Takeaways from IAPP’s Webinar - False Claims Act (FCA) cybersecurity enforcement has emerged as a Department of Justice (DOJ)...
California Governor Gavin Newsom Signs Seven New Data Privacy Laws
Key Takeaways - Recently signed California privacy laws carry new requirements for healthcare providers, data brokers, and companies t...
Wait! Don’t Inadvertently Give Generative AI Your Privileged and Confidential Information
As the landscape of generative artificial intelligence (AI) continues to evolve at an explosive rate, it is important to step back and ...
CCPA Imposes the Largest Administrative Fine to Date: What Companies Need to Know
On September 30, 2025, the California Privacy Protection Agency (CPPA) issued a final order against farm, ranch and rural lifestyle ret...
Life sciences panel sees headwinds & opportunities in emerging US trade, drug pricing, FDA policies
As part of the Hogan Lovells Horizons 2025 life sciences event series, our cross-practice team recently met in Boston to discuss shifti...
US State Consumer Data Privacy Laws: Comparison of Various Provisions
Our new chart identifies and analyzes several remaining provisions in U.S. state consumer data privacy laws that are not already covere...
California Enacts New Restrictions on Deceptive Use of Healthcare Licensing Terms by AI Systems
On October 11, 2025, California enacted Assembly Bill No. 489, introducing new regulatory measures to address the use of artificial int...
FDA Publishes Guidance Snapshot on Conducting Clinical Trials with Decentralized Elements
A decentralized clinical trial (DCT) includes clinical trials where trial-related activities occur at locations other than traditional ...